Sign up to save your podcasts
Or
Share Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer
Dr Stephanie L Graff from the Legorreta Cancer Center at Brown University in Providence, Rhode Island, and Dr Erica Mayer from Dana-Farber Cancer Institute in Boston discuss treatment decision-making involving approved and investigational strategies for the management of hormone receptor-positive breast cancer.
View all episodes
By Dr. Neil Love
4.4
6363 ratings
Dr Stephanie L Graff from the Legorreta Cancer Center at Brown University in Providence, Rhode Island, and Dr Erica Mayer from Dana-Farber Cancer Institute in Boston discuss treatment decision-making involving approved and investigational strategies for the management of hormone receptor-positive breast cancer.
More shows like Breast Cancer Update
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
317 Listeners
JAMA Clinical Reviews
497 Listeners
Lung Cancer Update
31 Listeners
Hematologic Oncology Update
73 Listeners
Prostate Cancer Update
14 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gynecologic Oncology Update
12 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
120 Listeners
Breastcancer.org Podcast
44 Listeners
ASCO Daily News
58 Listeners
The Curbsiders Internal Medicine Podcast
3,348 Listeners
Core IM | Internal Medicine Podcast
1,148 Listeners
ASCO Guidelines
45 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
368 Listeners
Oncology Today with Dr Neil Love
57 Listeners
Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing
0 Listeners